{"id":"W2460310329","doi":"10.4137/bcbcr.s39615","title":"Subgroup Analyses from a Phase 3, Open-Label, Randomized Study of Eribulin Mesylate versus Capecitabine in Pretreated Patients with Advanced or Metastatic Breast Cancer","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Basic and Clinical Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"Eribulin; Capecitabine; Medicine; Internal medicine; Metastatic breast cancer; Oncology; Breast cancer; Taxane; Cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006654643,0.002171843,0.003825859,0.0006242227,0.0004610797,0.001059874,0.0008893501,0.001366996,0.00708882],"category_scores_gemma":[0.006539538,0.0004232232,0.00798796,0.0006883433,0.0006542416,0.0007802875,0.0005812254,0.002121279,0.0004866997],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00142536,"about_ca_system_score_gemma":0.001929667,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009051196,"about_ca_topic_score_gemma":0.003807718,"domain_scores_codex":[0.9960191,0.002804178,0.0003769346,0.0003599182,0.0001984817,0.0002413329],"domain_scores_gemma":[0.9971137,0.001289655,0.0007790091,0.0003043661,0.0001905175,0.0003226676],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9716067,0.002237948,0.002032826,0.001498413,0.01093244,0.00006374017,0.00004477895,0.000495676,0.002121529,0.00006171644,0.000849188,0.008055078],"study_design_scores_gemma":[0.9169975,0.05852992,0.008218006,0.0001094807,0.01278279,0.00009117948,0.00004265076,0.0006723441,0.0009927453,0.0003358577,0.001199461,0.00002798194],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9617143,0.01425567,0.002014358,0.0007324584,0.0005909851,0.01196498,0.006234996,0.0001920092,0.00230021],"genre_scores_gemma":[0.9778703,0.003005167,0.001932519,0.001254641,0.0004494266,0.009610035,0.004229484,0.00004213748,0.001606397],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00708882,"threshold_uncertainty_score":0.03519356,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2671860688400545,"score_gpt":0.5786689249457595,"score_spread":0.311482856105705,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}